Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HOT mutation screening in human glioblastomas.
Krell D, Mulholland P, Stebbing J, Tomlinson I, Bardella C. Krell D, et al. Future Sci OA. 2015;1(3):FSO22. doi: 10.4155/fso.15.20. Future Sci OA. 2015. PMID: 26948489 Free PMC article.
Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis.
Bardella C, Al-Dalahmah O, Krell D, Brazauskas P, Al-Qahtani K, Tomkova M, Adam J, Serres S, Lockstone H, Freeman-Mills L, Pfeffer I, Sibson N, Goldin R, Schuster-Böeckler B, Pollard PJ, Soga T, McCullagh JS, Schofield CJ, Mulholland P, Ansorge O, Kriaucionis S, Ratcliffe PJ, Szele FG, Tomlinson I. Bardella C, et al. Among authors: krell d. Cancer Cell. 2016 Oct 10;30(4):578-594. doi: 10.1016/j.ccell.2016.08.017. Epub 2016 Sep 29. Cancer Cell. 2016. PMID: 27693047 Free PMC article.
Aristolochia: the malignant truth.
Krell D, Stebbing J. Krell D, et al. Lancet Oncol. 2013 Jan;14(1):25-6. doi: 10.1016/S1470-2045(12)70596-X. Lancet Oncol. 2013. PMID: 23276364 No abstract available.
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.
Brown N, McBain C, Nash S, Hopkins K, Sanghera P, Saran F, Phillips M, Dungey F, Clifton-Hadley L, Wanek K, Krell D, Jeffries S, Khan I, Smith P, Mulholland P. Brown N, et al. Among authors: krell d. PLoS One. 2016 May 27;11(5):e0156369. doi: 10.1371/journal.pone.0156369. eCollection 2016. PLoS One. 2016. PMID: 27232884 Free PMC article. Clinical Trial.
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
Rizzo FM, Vesely C, Childs A, Marafioti T, Khan MS, Mandair D, Cives M, Ensell L, Lowe H, Akarca AU, Luong T, Caplin M, Toumpanakis C, Krell D, Thirlwell C, Silvestris F, Hartley JA, Meyer T. Rizzo FM, et al. Among authors: krell d. Br J Cancer. 2019 Feb;120(3):294-300. doi: 10.1038/s41416-018-0367-4. Epub 2019 Jan 14. Br J Cancer. 2019. PMID: 30636773 Free PMC article.
High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective Analysis.
Hayes AR, Furnace M, Shah R, Rundell C, Muller G, Dehbi HM, Luong TV, Toumpanakis C, Caplin ME, Krell D, Thirlwell C, Mandair D. Hayes AR, et al. Among authors: krell d. Pancreas. 2021 Apr 1;50(4):516-523. doi: 10.1097/MPA.0000000000001808. Pancreas. 2021. PMID: 33939663
84 results